ARTICLE | Clinical News
ABBV-974: Phase I started
January 19, 2015 8:00 AM UTC
Galapagos began a double-blind, placebo-controlled, Belgian Phase I trial to evaluate single and multiple ascending doses of once-daily oral GLPG1837 in at least 40 healthy volunteers. The start of th...